Skip to content

Blue Ridge Bankshares BRBS Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

Centerspace logo
CenterspaceCSR
$43K-93.9%
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M
Macerich logo
MacerichMAC
$5.23M+4,335%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
Blue Ridge Bankshares logo
Blue Ridge BanksharesBRBS
$0-100%

Other financials

Income statement

See full
Revenue$19.3M-12.7%
Net income$836.0K+293%
EPS (diluted)$0.01+200%

Balance sheet

See full
Total debt$6.9M-16.6%
Total equity$248.8M-10.2%
Total assets$2.4B-10.1%

Cash flow

See full
Operating cash flow$15.0M+519%
CapEx$457.0K+1,728%
Free cash flow$14.6M+503%

Valuation

See full
Market cap$313.79M+4.6%
P/E26.2×
P/S3.5×0.0×

Profitability

See full
Net margin13.5%+8.8pp
FCF margin34.7%+31.8pp

Returns & leverage

See full
Return on equity13.2%-11.3pp
Debt / equity0.0×

Where this comes from

Reported directly by Blue Ridge Bankshares in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Blue Ridge Bankshares’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Blue Ridge Bankshares's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Blue Ridge Bankshares's exchange offer (note 12)?
Blue Ridge Bankshares (BRBS) reported exchange offer (note 12) of $0 in Q4 2025.
How has Blue Ridge Bankshares's exchange offer (note 12) changed year-over-year?
Blue Ridge Bankshares's exchange offer (note 12) decreased by 100.0% year-over-year, from $29.01M to $0.
What does exchange offer (note 12) mean?
This metric represents the total value or number of shares involved in exchange offers or equity conversion transactions where existing securities are swapped for new equity instruments. It reflects management's efforts to restructure capital, manage dilution, or optimize the balance sheet through non-cash financing activities. Investors monitor this to understand changes in capital structure and the potential impact on shareholder equity and earnings per share.